AKT1 and cardiac hypertrophy: TH-dependent cardiac hypertrophy was described as physiological hypertrophy mediated by the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway (2, 9, 68).